Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

[1]  M. Suckow,et al.  Intranasal vaccination of New Zealand white rabbits against pasteurellosis, using alginate-encapsulated Pasteurella multocida toxin and potassium thiocyanate extract. , 2000, Comparative medicine.

[2]  K. Switzer,et al.  Mucosal immunity to influenza without IgA: an IgA knockout mouse model. , 1999, Journal of immunology.

[3]  W. Brown,et al.  Bovine type 1 and type 2 responses. , 1998, Veterinary immunology and immunopathology.

[4]  Y. Suzuki,et al.  Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin. , 1998, Vaccine.

[5]  J. Eyles,et al.  Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. , 1998, Vaccine.

[6]  Mcdermott,et al.  Intranasal immunization with polymer‐grafted microparticles activates the nasal‐associated lymphoid tissue and draining lymph nodes , 1998, Immunology.

[7]  M. Zenkel,et al.  Filtration of Particulates in the Human Nose , 1998, The Laryngoscope.

[8]  J. Eyles,et al.  Oral and nasal immunization with microencapsulated clinically relevant proteins , 1998 .

[9]  L. Glickman,et al.  Experimental infection of young specific pathogen-free cats with Bartonella henselae. , 1997, The Journal of infectious diseases.

[10]  T. Speaker,et al.  Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates , 1997, Journal of virology.

[11]  M. Lamm.  Interaction of antigens and antibodies at mucosal surfaces. , 1997, Annual review of microbiology.

[12]  Y. Ikada,et al.  Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. , 1996, Vaccine.

[13]  D. Estes.  Differentiation of B cells in the bovine. Role of cytokines in immunoglobulin isotype expression. , 1996, Veterinary immunology and immunopathology.

[14]  Kinam Park,et al.  Oral vaccination with alginate microsphere systems , 1996 .

[15]  G. Letchworth,et al.  Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle. , 1996, Vaccine.

[16]  K. Mills,et al.  Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. , 1995, Vaccine.

[17]  K. Mills,et al.  Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. , 1995, Vaccine.

[18]  A. Coombes,et al.  Aspects of the design and delivery of microparticles for vaccine applications. , 1995, Journal of drug targeting.

[19]  C. Moser,et al.  Enhancement of rotavirus immunogenicity by microencapsulation. , 1994, Virology.

[20]  G. Splitter,et al.  Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host. , 1994, Vaccine.

[21]  M. Fujihara,et al.  An influence of the structure of alginate on the chemotactic activity of macrophages and the antitumor activity. , 1993, Carbohydrate research.

[22]  Y. Gao,et al.  Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle. , 1992, Virology.

[23]  S. Davis,et al.  Controlled release microparticles for vaccine development. , 1991, Vaccine.

[24]  Patrick Soon-Shiong,et al.  Induction of Cytokine Production from Human Monocytes Stimulated with Alginate , 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[25]  D. O'hagan,et al.  Intestinal translocation of particulates — implications for drug and antigen delivery , 1990 .

[26]  C. Hjerpe.  Bovine vaccines and herd vaccination programs. , 1990, The Veterinary clinics of North America. Food animal practice.

[27]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[28]  M. Alley,et al.  Respiratory tract-associated lymphoid tissue in conventionally raised sheep. , 1989, Journal of comparative pathology.

[29]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[30]  J. Bienenstock.  Immunology of the lung and upper respiratory tract , 1984 .

[31]  O Ouchterlony,et al.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[32]  Wilkie Bn.  Respiratory tract immune response to microbial pathogens. , 1982 .

[33]  B O Stuart,et al.  Deposition and clearance of inhaled particles. , 1976, Environmental health perspectives.

[34]  O. Smidsrod,et al.  Molecular basis for some physical properties of alginates in the gel state , 1974 .

[35]  A. R. Thomson,et al.  Uptake of Small Resin Particles (1–5µ Diameter) by the Alimentary Canal of the Calf , 1960, Nature.